Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Reumatología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase IIIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Comparative Study of Abatacept or Infliximab in Combination With Methotrexate in Controlling Disease Activity in Subjects With Rheumatoid Arthritis Having an Inadequate Clinical Response to Methotrexate
INTERVENTIONAL
Inicio: 1 de feb de 2005
ID: NCT00095147
Completado
Fase 2
ClinicalTrials.gov
A Phase II, Randomized Multi-Center, Double-Blind Study of Tranilast With Concomitant Methotrexate (MTX) Compared to MTX Alone in Patients With Active Rheumatoid Arthritis (RA)
INTERVENTIONAL
Inicio: 1 de mar de 2009
ID: NCT00882024
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Afimetoran in Participants With Active Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 11 de oct de 2021
ID: NCT04895696
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging, Multi-Center Study to Evaluate the Efficacy and Safety of BMS-945429 Subcutaneous Injection in Adults With Active Psoriatic Arthritis
INTERVENTIONAL
Inicio: 1 de dic de 2011
ID: NCT01490450
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Subjects With Active Nonradiographic Axial Spondyloarthritis
INTERVENTIONAL
Inicio: 13 de jul de 2015
ID: NCT02407223
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 27 de jun de 2013
ID: NCT01885078
Reclutando
Fase 2
ClinicalTrials.gov
Efficacy and Safety of SAR441344 in the Treatment of Systemic Lupus Erythematosus: A Randomized, Double Blind, Placebo-controlled, Phase 2, Proof of Concept Study
INTERVENTIONAL
Inicio: 10 de nov de 2021
ID: NCT05039840
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Who Had an Inadequate Response and/or Intolerance to One Prior Anti-Tumor Necrosis Factor Alpha Agent
INTERVENTIONAL
Inicio: 28 de sept de 2021
ID: NCT04936308
Completado
Fase 3
ClinicalTrials.gov
A Phase III, 12-Week, Multicentre, Double-Blind, Randomised, Placebo- and Active Comparator-Controlled, Parallel Group Study to Investigate the Efficacy and Safety of GW406381, 5mg, 10mg, 25mg, and 50mg Administered Orally Once Daily, in Adults With Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 1 de jun de 2005
ID: NCT00113308
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
INTERVENTIONAL
Inicio: 5 de abr de 2019
ID: NCT03773965
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Parallel Group Study of the Safety and Effect on Clinical Outcome of Tocilizumab SC Versus Tocilizumab IV, in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs), in Patients With Moderate to Severe Active Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 1 de sept de 2010
ID: NCT01194414
Terminado
Fase 2
ClinicalTrials.gov
An Open-label Extension Study to Evaluate the Long-term Safety of Mavrilimumab in Adult Subjects With Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 28 de ene de 2013
ID: NCT01712399
Completado
ClinicalTrials.gov
Is the Artificial Pancreas, Without Carbohydrate Counting, Efficient and Safe for Ambulatory Patients With Type 1 Diabetes
INTERVENTIONAL
Inicio: 8 de mar de 2021
ID: NCT04793165
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Study of Secukinumab to Demonstrate the Efficacy at 24 Weeks and to Assess the Safety, Tolerability and Long Term Efficacy up to 2 Years in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNFα Agents (CAIN457F2302) and a Three Year Extension Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Rheumatoid Arthritis (CAIN457F2302E1)
INTERVENTIONAL
Inicio: 30 de ago de 2011
ID: NCT01377012
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 12 de ago de 2020
ID: NCT04294667
Completado
Fase 3
ClinicalTrials.gov
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 5 de feb de 2007
ID: NCT00413699
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Controlled Study to Evaluate PK, PD, Safety and Efficacy of GP2013 and Rituximab in Patients With Rheumatoid Arthritis Refractory or Intolerant to Standard DMARDs and up to Three Anti-TNF Therapies.
INTERVENTIONAL
Inicio: 1 de ene de 2011
ID: NCT01274182
Completado
ClinicalTrials.gov
Development of Complementary Tools for the Differential Diagnosis of Fibromyalgia Based on Cognitive Task Performance
OBSERVATIONAL
Inicio: 25 de abr de 2023
ID: NCT05910372
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b Dose Ranging Study to Evaluate the Efficacy and Safety of Rozibafusp Alfa (AMG 570) in Subjects With Active Systemic Lupus Erythematosus (SLE) With Inadequate Response to Standard of Care (SOC) Therapy
INTERVENTIONAL
Inicio: 19 de feb de 2020
ID: NCT04058028
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
INTERVENTIONAL
Inicio: 9 de sept de 2019
ID: NCT03843125
Anterior
1
...
9
10
11
...
434
Siguiente
Filtros